Phase III trial of lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma (E4A03): A trial coordinated by the Eastern Cooperative Oncology Group
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: lenalidomide, dexamethasone, newly diagnosed multiple myeloma, high-dose dexamethasone, low-dose dexamethasone, combination chemotherapy, overall survival, response rate, thromboembolism, drug toxicity, Eastern Cooperative Oncology Group, interim analysis, non-hematologic toxicity, hyperglycemia
Open Access status: closed
OpenAlex ID: W1867927052
